Trouble logging in? Forgot password? We can help!
215-685-6784
215-238-6944
Fill out both forms, then either email or fax them to us at the contact above.
Provider? Stay in the know
Get the newest information from the Immunization Program right in your inbox!
Sign upComplete the survey! The Philadelphia Immunization Program thanks you for participating in the COVID-19 Bridge Access Program. You played a crucial role in ensuring underinsured and uninsured adults in Philadelphia could access COVID-19 vaccines. Now that the Bridge Access Program has ended, we're asking providers who were enrolled to complete a Provider Satisfaction Survey. Thank you...
2024 – 2025 COVID-19 Vaccines Available to Order As a reminder, the federally funded Bridge Access Program (BAP) ended on August 12, 2024. Last season’s 2023- 2024 COVID-19 vaccines are now unauthorized and should not be administered. If you have not done so already, remove all 2023 –...
New Flu and COVID-19 Products Available VFC providers can now order: 2024-2025 Novavax COVID-19 products for 12 years and older Flucelvax (Sequirus) FluMist (AstraZeneca) Make sure that your EHR/EMR is set up to report this year’s COVID-19 products. These are the vaccines available: When placing COVID-19 orders, please remember: Complete a current COVID-19 reconciliation. Submit your...
2024-2025 VFC COVID-19 Product Availability VFC providers can order Moderna and Pfizer 2024-2025 COVID-19 products for all ages beginning on September 9 at 12pm. Make sure that your EHR/EMR is set-up to report this year’s COVID-19 products. These are the vaccines available this year: When placing COVID-19 orders, please...
Bridge Access Program Update Thank you for your continued efforts in ensuring that Philadelphia community members have access to the COVID-19 vaccine. We regret to inform you that the federally funded Bridge Access Program (BAP) has ended before the original closure date of December 31st, 2024....
2023-2024 COVID-19 Products Deauthorized for Use Effective immediately, all 2023-2024 COVID-19 products are no longer approved for use. Stop administering all 2023-2024 COVID-19 vaccines. Remove all 2023-2024 COVID-19 vaccines from storage units immediately, even if they are not expired. Discard any open vials of vaccine. Return any unopened vials or...
Join Us for a COVID-19 Product Update Join the PDPH Immunization Program and our pharmaceutical partners for a virtual townhall regarding the 2024 - 2025 COVID-19 product update. This informative session is for both pediatric and adult primary care providers (PCPs) who would like to learn...
2023-2024 Pfizer (5 yrs-11 yrs and 12+) COVID-19 Vaccines No Longer Available As of Monday, June 10, 2024, the Pfizer 2023-2024 COVID-19 vaccine, 5 yrs – 11 yrs, and Comirnaty (Pfizer), 2023-2024 COVID-19 vaccine, 12 yrs + products are no longer available to order through the Vaccines for Children...
Novavax COVID-19 Vaccine Now Expired! Read on for more upcoming changes in COVID-19 product availability. As of Friday, May 31, 2024 all doses of Novavax COVID-19 vaccine have expired. Remove any remaining doses from your storage units at this time. Use this guide to waste any opened vaccine. Use this guide to return unopened...
2023-2024 COVID-19 Vaccine Update Dosing Schedule & Available Products Review the dosing schedule and available products for 2023-2024 COVID-19 vaccine below. We don’t yet know the exact timing of when 2024–2025 COVID-19 vaccines will be available. However, FDA authorization or approval of 2024–2025 COVID-19 vaccines is anticipated...
COVID-19 Vaccine Return Guidance Unopened vaccines should be returned when: The manufacturer expiration date has passed. The vaccines are no longer viable due to out-of-range temperatures. The vaccine has passed its beyond-use-date (BUD). When returning COVID-19 vaccines that have passed their beyond-use-date, remember to select Other as the return reason and include “Past...
Tips for Managing Short-Dated COVID-19 Vaccine Inventory COVID-19 vaccine shipped by McKesson in the following months will be short-dated, meaning the manufacturer expiration dates will be shorter than usual. McKesson will continue distributing COVID-19 doses until the vaccines are within 30 days of expiry. Here are...
Protect Your Patients from Flu, COVID-19, and RSV There are currently high rates of respiratory illness nationwide, including flu, COVID-19, and RSV. Continue to recommend immunization to prevent severe illness and hospitalization. Below, review eligibility recommendations from the CDC and stay updated on flu products available...
Reminder for Bridge Access Providers Only adults 18 and over who are uninsured or underinsured are eligible to receive a COVID-19 vaccine under the Bridge Access Program (BAP). Screening an individual for eligibility before giving a BAP COVID-19 dose is a requirement outlined in the provider agreement. Uninsured:...
COVID-19 Vaccine Returns Unopened vaccines should be returned when: The manufacturer expiration date has passed. The vaccines are no longer viable due to out-of-range temperatures. The vaccine has passed its beyond-use-date (BUD). When returning COVID-19 vaccines that have passed their beyond-use-date,remember to select Other as the return reason and include...
New Refrigerated Pfizer 12+ COVID-19 Vaccine A new presentation of Comirnity (Pfizer COVID-19 vaccine for 12+ year olds) (NDC 00069-2377-10) is now available to order. The new presentation: is a carton of 10 prefilled syringes. is a refrigerated formulation that must be stored between 2°C and 8°C (36°F and 46°F). Do not...
Deauthorized COVID-19 Products As a reminder, only the approved 2023 - 2024 COVID-19 products listed below may be administered at this time: Authorized 2023 - 2024 ProductsFormulation: Monovalent XBB.1.5 Pfizer 12+: NDC 00069-2362-10 Pfizer 5-11: NDC 59267-4331-02 Pfizer 6mo-4yrs: NDC 59267-4315-02 Moderna 12+: NDC 8077-0102-95 Moderna 6mo-11yrs: NDC 8077-0287-92 Novavax 12+: NDC 80631-0105-02 Previously...
Nirsevimab (Beyfortus) and COVID-19 Updates Nirsevimab Due to high demand and limited supply cited by the CDC, nirsevimab (Beyfortus) ordering through VFC has been put on hold as of October 17, 2023. The CDC is working with Sanofi to secure a supply of this immunization within the...
